Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors
Objectives: Multiple myeloma (MM) accounts for 10% of hematologic malignancies. However, most of the patients suffered from relapsed/refractory disease. We would like to expand CAR T cell therapy to treat MM using our current platform. Methods: BCMA CAR T lymphocytes were generated for volunteers or...
Saved in:
Main Author: | Prasongtanakij S. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82916 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growth
by: Zhang, X, et al.
Published: (2022) -
Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma
by: Yuti P.
Published: (2023) -
CHIMERIC ANTIGEN RECEPTOR BASED ON T CELL RECEPTOR LIKE ANTIBODY
by: WU LING
Published: (2020) -
IMPROVING THE EFFICACY OF CHIMERIC ANTIGEN RECEPTOR-T CELLS FOR CANCER THERAPY
by: NATASHA VINANICA
Published: (2020) -
EVALUATION OF NOVEL ANTIBODIES FOR CHIMERIC ANTIGEN RECEPTOR T CELL APPLICATIONS
by: LEONARD WEN YAN LEONG
Published: (2021)